Abstract:Toxoplasma gondii is an obligate intracellular parasite that infects one-third of the world's human population and establishes infection in the brain. Cerebral immune cell infiltration is critical for controlling the parasite, but little is known about the molecular cues guiding immune cells to the brain during infection. Activated astrocytes produce CCL2, a chemokine that mediates inflammatory monocyte recruitment to tissues by binding to the CCR2 receptor. We detected elevated CCL2 production in the brains of C57BL/6J mice by 15 days after T . gondii infection. Utilizing confocal microscopy and intracellular flow cytometry, we identified microglia and brain-infiltrating myeloid cells as the main producers of CCL2 during acute infection, and CCL2 was specifically produced in regions of parasite infection in the brain. In contrast, astrocytes became the dominant CCL2 producer during chronic T . gondii infection. To determine the role of astrocyte-derived CCL2 in mobilizing immune cells to the brain and controlling T . gondii infection, we generated GFAP-Cre x CCL2 fl/fl mice, in which astrocytes are deficient in CCL2 production. We observed significantly decreased immune cell recruitment and increased parasite burden in the brain during chronic, but not acute, infection of mice deficient in astrocyte CCL2 production, without an effect on peripheral immune responses. To investigate potential mechanisms explaining the reduced control of T . gondii infection, we analyzed key antimicrobial and immune players in host defense against T . gondii and detected a reduction in iNOS + myeloid cells, and T . gondii -specific CD4 + T cells in the knockout mice. These data uncover a critical role for astrocyte-derived CCL2 in immune cell recruitment and parasite control in the brain during chronic, but not acute, T . gondii infection. Neuroinflammation plays an important role in protecting the brain against infection, but it must be controlled to prevent damage to the brain. Toxoplasma gondii is an obligate intracellular foodborne parasite that infects one-third of the world's human population. Among pathogens, T . gondii has the rare ability to cross the blood-brain barrier and establish chronic infection in the brain, inducing a protective, but non-sterilizing immune response. In this study, we examined T . gondii infection of mice to understand the factors driving the neuroinflammatory response to infection of the brain. We determined that the cells producing the potent chemokine, CCL2, changed over the course of infection: myeloid cells were the main CCL2 producers during acute infection, whereas astrocytes became the dominant CCL2 producers during chronic infection. Additionally, the ablation of CCL2 production specifically from astrocytes reduced immune cell recruitment to the brain and decreased control of the parasite during chronic infection. Therefore, astrocyte-derived CCL2 plays a critical role in the control of chronic, but not acute, T . gondii infection.

Locally generated C3 regulates the clearance of Toxoplasma gondii by IFN-γ-primed macrophage through regulation of xenophagy

Host Autophagy Limits Toxoplasma Gondii Proliferation in the Absence of IFN-γ by Affecting the Hijack of Rab11A-positive Vesicles

Toxoplasma Gondii CDPK3 Controls the Intracellular Proliferation of Parasites in Macrophages.

CCAAT/Enhancer-Binding Protein Β Mediates the Killing of Toxoplasma Gondii by Inducing Autophagy in Nonhematopoietic Cells.

Targeted Overexpression of Cyclic AMP-dependent Protein Kinase Subunit in Toxoplasma Gondii Promotes Replication and Virulence in Host Cells.

Parasite-induced IFN-γ regulates host defense via CD115 and mTOR-dependent mechanism of tissue-resident macrophage death

The role of SIRT1 in the process of Toxoplasma gondii infection of RAW 264.7 macrophages

The non-glycosylated protein of <i>Toxocara canis</i> MUC-1 interacts with proteins of murine macrophages

Toxoplasma Gondii-Induced Activation of EGFR Prevents Autophagy Protein-Mediated Killing of the Parasite.

Toxoplasma gondii infection induces the expression of the chemokine CXCL16 in macrophages to promote chemoattraction of CXCR6+ cells

Toxoplasma gondii eIF-5A Modulates the Immune Response of Murine Macrophages In Vitro

Deficiency in astrocyte CCL2 production reduces neuroimmune control of Toxoplasma gondii infection

Toxoplasma Gondii Infection Induces High Mobility Group Box 1 Released from Mouse Macrophages.

TgATG9 is required for autophagosome biogenesis and maintenance of chronic infection in Toxoplasma gondii

Host E3 ubiquitin ligase ITCH mediates Toxoplasma gondii effector GRA35-triggered NLRP1 inflammasome activation and cell-autonomous immunity

Toxoplasma gondii glycosylphosphatidylinositols up-regulate major histocompatibility complex (MHC) molecule expression on primary murine macrophages

ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells

The role of IFN-γ-mediated host immune responses in monitoring and the elimination of Toxoplasma gondii infection

Effects of Recombinant Toxoplasma Gondii Citrate Synthase I on the Cellular Functions of Murine Macrophages in Vitro

Comparative studies of macrophage-biased responses in mice to infection with Toxoplasma gondii ToxoDB #9 strains of different virulence isolated from China

Endogenous IL-27 during toxoplasmosis limits early monocyte responses and their inflammatory activation by pathological T cells